ARK Genomic Revolution ETF (BATS:ARKG) Hits New 1-Year High – Here’s Why

ARK Genomic Revolution ETF (BATS:ARKG) reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $43.98 and last traded at $43.86, with a volume of 1805851 shares trading hands. The stock had previously closed at $42.91.

ARK Genomic Revolution ETF Stock Performance

The company’s fifty day simple moving average is $33.57 and its two-hundred day simple moving average is $30.76.

Institutional Investors Weigh In On ARK Genomic Revolution ETF

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ARKG. JPMorgan Chase & Co. raised its holdings in ARK Genomic Revolution ETF by 30.6% during the 4th quarter. JPMorgan Chase & Co. now owns 5,149,454 shares of the company’s stock valued at $149,180,000 after acquiring an additional 1,205,541 shares during the period. Morgan Stanley increased its holdings in shares of ARK Genomic Revolution ETF by 42.2% in the 4th quarter. Morgan Stanley now owns 4,025,965 shares of the company’s stock worth $116,632,000 after buying an additional 1,193,795 shares during the last quarter. BNP Paribas Financial Markets raised its position in shares of ARK Genomic Revolution ETF by 49.7% during the 4th quarter. BNP Paribas Financial Markets now owns 3,514,980 shares of the company’s stock valued at $101,829,000 after buying an additional 1,167,558 shares in the last quarter. Wells Fargo & Company MN raised its position in shares of ARK Genomic Revolution ETF by 29.1% during the 4th quarter. Wells Fargo & Company MN now owns 1,287,390 shares of the company’s stock valued at $37,296,000 after buying an additional 290,301 shares in the last quarter. Finally, LPL Financial LLC lifted its holdings in shares of ARK Genomic Revolution ETF by 9.0% during the 4th quarter. LPL Financial LLC now owns 824,961 shares of the company’s stock worth $23,899,000 after acquiring an additional 68,267 shares during the last quarter.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.